Isabel Fidalgo Carvalho
Recherche partenariat En recherche d'un consultant En recherche de financements
Equigerminal is a Vet biotech specialised in viral discovery, monitoring and control by using an One Health approach.
Emerging infectious diseases (EIDs) and climate change are the threats of the coming decades. . It’s is estimated that there are as 1,67 Million unknown viruses out there. The SARS-CoV-2 was one of this virus that emerged from animals and caused the current pandemics, but many others are harbouring and evolving in animals that need to be characterized, monitored and controled for the preparedness of the next ;
Our ativities are mainly the developemnt of innovative tools - diagnosis, antivirals and vaccines- to control emerging viral threats.
Our projects:
1- Refinement of a R&D+I platform to monitor emerging viral threats and enable rapid develpment of diagnostics, antivirals and vaccines
2- Refinenment of diagnosis, antivirals and vaccines for two newly discovered virus and better understanding of the zoonotic potential of this newly uncovered ;
To date Equigerminal discovered two uncovered potential letal virus, the lentivirus New Equine Virus (NEV) in Equines and the X-virus in Humans that are associated to fatal respiratory and neurologic disorders.
3- Refinement and monitoring of SARS-CoV-2 in animal ;
Mots clés et domaine d'activité:
Accédez au prémier réseau pour la cooperation européenne
Se connecter
ou
Créer un compte
Pour accéder à toutes les informations disponibles
Vétérinaire
Santé et bien-être des animaux
Soins de santé
Médicaments
Biotechnologie
il y a 3 ans
Vétérinaire
Santé et bien-être des animaux
Biodiversité
Innovation
Développement durable
Médicaments
Biotechnologie
Innovation & Recherche
Fonds européen agricole pour le développement rural (...
il y a 3 ans
S'il vous plaît Se connecter pour voir cette section